Company overview
Leica Microsystems develops high-tech precision microscopes and imaging systems for life science research, biotechnology, medicine, and pharmaceutical analysis of microstructures and nanostructures. Their portfolio includes digital microscopes for biological sciences, materials analysis, and industrial quality assurance, enhanced by machine learning and automation. As part of Danaher Corporation, they operate globally with headquarters in Wetzlar, Germany, and presence in over 100 countries.
Microscopes and Imaging Systems is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include leica microsystems, pharma microscopy, life science microscopes, imaging systems, biotech r&d tools.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Microscopes and Imaging Systems include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.leica-microsystems.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- leica microsystems, pharma microscopy, life science microscopes, imaging systems, biotech r&d tools
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What microscopy solutions does Leica offer for pharmaceutical R&D?
- Leica provides advanced microscopes for life science research, biotechnology, and analysis of microstructures/nanostructures, including digital series like DM4000 B/DM6000 B for biological sciences and imaging cameras with high resolution and fast live speeds.
- What are Leica Microsystems' global capabilities and manufacturing footprint?
- Headquartered in Wetzlar, Germany, Leica has 12 manufacturing facilities in 7 countries, sales/service in 19 countries, and representation in over 100 countries through an international dealer network.
- Is Leica Microsystems compliant with regulatory standards for pharma?
- As a Danaher Corporation company with 175+ years in scientific instruments and a capability statement (EIN: 22-2701363), Leica adheres to high-quality standards for optics and systems used in regulated fields like medicine, biotech, and forensics.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
